Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 08, 2021 05:15 ET | Source: PCI Biotech Holding ASA

PCI Biotech: Presentation of fimaChem for bile duct cancer at IPA masterclass series

Oslo (Norway), 8 November 2021 – PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company, today announced that the coordinating principal investigator for the RELEASE trial, Prof. Dr. Jörg...
May 07, 2021 01:00 ET | Source: PCI Biotech Holding ASA

PCI Biotech first quarter 2021 interim results

Oslo (Norway), 7 May 2021 – PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company, today announces its interim Q1 2021 results. Please find enclosed the report and presentation. ...
May 05, 2021 05:00 ET | Source: PCI Biotech Holding ASA

OliX Pharmaceuticals and PCI Biotech announce a collaboration to combine OliX asiRNA and PCI Biotech fimaNAc technologies

Suwon, South Korea and Oslo, Norway, May, 5th 2021 – OliX Pharmaceuticals Inc. (KOSDAQ: 226950) a leading developer of RNAi therapeutics, and PCI Biotech (OSE: PCIB), a cancer focused...
February 24, 2021 01:00 ET | Source: PCI Biotech Holding ASA

PCI Biotech fourth quarter and preliminary full year 2020 results

Oslo (Norway), 24 February 2021 – PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company, today announces its interim Q4 and preliminary full year 2020 results. Please find enclosed the...
February 10, 2021 02:31 ET | Source: PCI Biotech Holding ASA

PCI Biotech - release of the RNA Therapeutics Virtual Conference presentation

Oslo (Norway), 10 February 2021 – PCI Biotech (OSE: PCIB), a clinical-stage biopharma company developing innovative therapeutics that address significant unmet medical needs in cancer today released...
March 26, 2020 04:12 ET | Source: PCI Biotech Holding ASA

PCI Biotech: US patent for the vaccine technology (fimaVacc) with a new important class of adjuvants

Oslo (Norway), 26 March 2020 – PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company, today announces that the U.S. Patent and Trademark Office (USPTO) has informed the company that a...
February 26, 2020 01:00 ET | Source: PCI Biotech Holding ASA

PCI Biotech's fourth quarter and preliminary 2019 results

Oslo (Norway), 26 February 2020 – PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company, today announces its interim fourth quarter and preliminary 2019 results. Please find enclosed the...